CRNX Crinetics Pharmaceuticals, Inc.

Fundamentals / CIK 0001658247 / USD

Crinetics Pharmaceuticals, Inc. reported $42.16M in revenue and a net loss of $501.6M for the trailing twelve months ended June 30, 2026 (up 2336.3% year over year), with a 15.7% gross margin and a -1302.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CRNX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$56.72M$28.36M$0-$435.7MFY 2016 Revenue: $589KFY 2016 Net Income: -$6.02M2016FY 2017 Revenue: $2.04MFY 2017 Net Income: -$9.16M2017FY 2018 Revenue: $2.43MFY 2018 Net Income: -$27.11M2018FY 2019 Revenue: $1.19MFY 2019 Net Income: -$50.42M2019FY 2020 Revenue: $71KFY 2020 Net Income: -$73.81M2020FY 2021 Revenue: $1.08MFY 2021 Net Income: -$107.6M2021FY 2022 Revenue: $4.74MFY 2022 Net Income: -$163.9M2022FY 2023 Revenue: $4.01MFY 2023 Net Income: -$214.5M2023FY 2024 Revenue: $1.04MFY 2024 Net Income: -$298.4M2024FY 2025 Revenue: $7.70MFY 2025 Net Income: -$465.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $7.70M $1.04M $4.01M $4.74M $1.08M $71K $1.19M $2.43M $2.04M $589K
Cost of Revenue $1.08M $0 $0 -- -- -- -- -- -- --
Gross Profit $6.62M $1.04M $4.01M -- -- -- -- -- -- --
Research & Development $332.1M $240.2M $168.5M $130.2M $84.25M $57.00M $41.51M $24.48M $9.23M $5.10M
Selling, General & Admin $191.3M $99.74M $58.09M -- -- -- -- -- -- --
Total Operating Expenses -- $339.9M $226.6M $172.6M $108.8M $75.02M $55.02M $31.14M $11.17M $6.63M
Operating Income -$516.8M -$338.9M -$222.6M -$167.9M -$107.7M -$74.95M -$53.83M -$28.71M -$9.13M -$6.04M
EBITDA -$512.9M -$336.1M -$221.5M -$166.9M -$106.8M -$74.00M -$52.95M -$28.24M -$9.00M -$5.95M
Interest Income $51.99M $41.44M $13.44M $4.32M $157K $991K $3.46M $1.75M $26K $37K
Interest Expense -- -- -- -- -- -- -- -- $8.0K $11K
Income Before Tax -$465.1M -$298.4M -$214.5M -$163.9M -$107.6M -$73.81M -$50.42M -$27.11M -$9.16M -$6.02M
Income Tax Expense $180K $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$465.3M -$298.4M -$214.5M -$163.9M -$107.6M -$73.81M -$50.42M -$27.11M -$9.16M -$6.02M
Basic EPS -$4.95 -$3.69 -$3.69 -$3.15 -$2.80 -$2.42 -$2.09 -$2.23 -$6.68 -$5.96
Diluted EPS -$4.95 -$3.69 -$3.69 -$3.15 -$2.80 -$2.42 -$2.09 -$2.23 -$6.68 -$5.96
Basic Shares Outstanding 94.1M 80.8M 58.1M 52.0M 38.4M 30.4M 24.2M 12.1M 1.4M 1.0M
Diluted Shares Outstanding 94.1M 80.8M 58.1M 52.0M 38.4M 30.4M 24.2M 12.1M 1.4M 1.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue $25.12M $10.73M $6.16M $143K $1.03M $361K $0 $0
Cost of Revenue $154K $200K -- -- $0 $0 -- --
Gross Profit $24.96M $10.53M -- -- $1.03M $361K -- --
Research & Development $99.85M $100.1M $85.05M $90.46M $80.30M $76.24M $66.57M $61.91M
Selling, General & Admin -- -- -- -- $49.84M $35.53M -- --
Total Operating Expenses -- -- -- $142.7M $130.1M $111.8M $94.75M $87.80M
Operating Income -$132.5M -$140.4M -$133.7M -$142.6M -$129.1M -$111.4M -$94.75M -$87.80M
EBITDA -$131.4M -$139.2M -$132.7M -$141.6M -$128.2M -$110.5M -$93.96M -$87.03M
Interest Income $12.03M $12.66M $11.16M $12.54M $13.46M $14.83M $14.37M $11.01M
Income Before Tax -- -- -- -$130.1M -- -- -- -$76.83M
Net Income -$120.9M -$127.8M -$122.8M -$130.1M -$115.6M -$96.77M -$80.59M -$76.83M
Basic EPS -$1.14 -$1.23 -- -$1.38 -$1.23 -$1.04 -- -$0.96
Diluted EPS -$1.14 -$1.23 -- -$1.38 -$1.23 -$1.04 -- -$0.96
Basic Shares Outstanding 105.6M 104.1M -- 94.2M 93.8M 93.1M -- 80.1M
Diluted Shares Outstanding 105.6M 104.1M -- 94.2M 93.8M 93.1M -- 80.1M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $101.5M $264.5M $54.90M $32.67M $200.7M $93.09M $40.33M $44.97M $14.19M
Short-Term Investments $926.4M $1.09B $503.7M $301.8M $133.0M $77.79M $78.07M $118.9M --
Cash & Short-Term Investments $1.00B $1.40B $558.6M $334.4M $333.7M $170.9M $118.4M $163.9M $14.19M
Accounts Receivable, Net $592K $0 -- -- -- -- -- -- --
Inventory $2.02M $0 -- -- -- -- -- -- --
Other Current Assets $3.46M $2.39M $448K $1.93M $912K $1.02M $668K $876K $239K
Total Current Assets $1.05B $1.38B $574.2M $345.2M $344.7M $177.5M $123.3M $166.7M $15.16M
Property, Plant & Equipment, Net $14.30M $12.07M $10.88M $3.50M $2.83M $3.18M $3.95M $4.23M $400K
Other Non-Current Assets -- $2.83M $2.00M $37K $0 $40K $82K -- $33K
Total Non-Current Assets $77.92M $59.20M $61.20M $6.99M $6.29M $5.95M $7.04M $4.73M $433K
Total Assets $1.13B $1.43B $635.4M $352.2M $351.0M $183.4M $130.4M $171.4M $15.60M
Accounts Payable $22.61M $5.85M $6.55M $6.88M $3.42M -- -- $1.46M $403K
Deferred Revenue (Current) $1.24M $2.18M $2.06M $2.20M -- -- -- -- --
Other Current Liabilities -- -- -- $1.05M $939K $835K $724K $381K --
Total Current Liabilities $85.07M $59.68M $43.94M $27.72M $15.99M $10.49M $8.34M $7.92M $897K
Deferred Revenue (Non-Current) $3.81M $4.70M $4.75M $6.10M $0 -- -- -- --
Other Non-Current Liabilities $3.24M $829K $0 -- -- -- -- -- --
Total Non-Current Liabilities $49.10M $50.10M $52.30M $8.12M $3.08M $4.04M $4.90M $3.27M $23K
Total Liabilities $134.2M $109.8M $96.25M $35.85M $19.07M $14.53M $13.24M $11.19M $920K
Total Debt (incl. Leases) $48.54M $51.72M $51.73M $3.08M $4.01M $4.85M $5.57M -- --
Common Stock $2.41B $2.28B $253K $0 $607.6M $336.5M $210.8M $24K $1.0K
Retained Earnings -$1.42B -$952.1M -$653.7M -$439.2M -$275.3M -$167.6M -$93.80M -$43.38M -$16.27M
Accumulated Other Comp. Income $1.86M $963K $977K -$3.93M -$382K $25K $148K $61K --
Total Stockholders' Equity $992.1M $1.32B $539.1M $316.3M $331.9M $168.9M $117.1M $160.2M -$15.02M
Total Equity $992.1M $1.32B $539.1M $316.3M $331.9M $168.9M $117.1M $160.2M -$15.02M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $55.50M $114.3M $101.5M $110.9M $53.73M $94.57M $264.5M $317.3M
Short-Term Investments $1.15B $1.18B $926.4M $981.4M $1.14B $1.18B $1.09B $545.4M
Cash & Short-Term Investments $1.20B $1.30B $1.00B $1.10B $1.20B $1.30B $1.40B $862.7M
Accounts Receivable, Net $11.96M $5.68M $592K -- -- -- $0 --
Inventory $3.49M $3.06M $2.02M -- -- -- $0 --
Other Current Assets $4.71M $6.43M $3.46M $4.81M $3.69M $2.70M $2.39M $1.49M
Total Current Assets $1.24B $1.32B $1.05B $1.12B $1.22B $1.29B $1.38B $877.6M
Property, Plant & Equipment, Net $13.07M $13.50M $14.30M $14.38M $14.67M $12.63M $12.07M $11.71M
Other Non-Current Assets -- -- -- -- -- $14.15M $2.83M $2.51M
Total Non-Current Assets $77.52M $78.91M $77.92M $74.76M $72.31M $70.27M $59.20M $59.79M
Total Assets $1.32B $1.40B $1.13B $1.20B $1.29B $1.36B $1.43B $937.4M
Accounts Payable $13.25M $12.88M $22.61M $6.11M $11.32M $9.84M $5.85M $4.94M
Deferred Revenue (Current) $1.67M $1.27M $1.24M -- -- -- $2.18M $1.69M
Total Current Liabilities $79.92M $71.09M $85.07M $74.16M $68.40M $57.31M $59.68M $53.56M
Deferred Revenue (Non-Current) $3.46M $3.35M $3.81M $4.11M $3.99M $4.31M $4.70M $5.20M
Other Non-Current Liabilities $5.93M $4.93M $3.24M $2.89M $2.33M $1.77M $829K $511K
Total Non-Current Liabilities $50.01M $49.59M $49.10M $49.71M $49.65M $50.02M $50.10M $50.83M
Total Liabilities $129.9M $120.7M $134.2M $123.9M $118.0M $107.3M $109.8M $104.4M
Total Debt (incl. Leases) $47.19M $47.85M $48.54M $49.14M $49.94M $50.82M $51.72M $52.54M
Common Stock $2.86B $2.83B $2.41B $2.36B $2.33B $2.30B $2.28B $1.70B
Retained Earnings -$1.67B -$1.55B -$1.42B -$1.29B -$1.16B -$1.05B -$952.1M -$871.5M
Accumulated Other Comp. Income -$3.01M -$1.25M $1.86M $2.19M $1.62M $2.00M $963K $2.04M
Total Stockholders' Equity $1.19B $1.28B $992.1M $1.07B $1.17B $1.25B $1.32B $833.0M
Total Equity $1.19B $1.28B $992.1M $1.07B $1.17B $1.25B $1.32B $833.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$465.3M -$298.4M -$214.5M -$163.9M -$107.6M -$73.81M -$50.42M -$27.11M -$9.16M -$6.02M
Depreciation & Amortization $3.90M $2.80M $1.10M $983K $922K $948K $887K $471K $128K $92K
Stock-Based Compensation $91.02M $69.39M $40.94M $28.27M $17.35M $10.43M $6.29M $2.32M $271K $270K
Change in Receivables -$592K $0 $0 -- -- -- -- -- -- --
Change in Inventory -$2.02M $0 $0 -- -- -- -- -- -- --
Operating Cash Flow -$377.9M -$230.2M -$168.6M -$115.2M -$88.59M -$62.03M -$46.38M -$19.46M -$9.48M -$5.47M
Capital Expenditure -$5.76M -$3.84M -$4.69M -$1.66M -$436K -$186K -$492K -$1.06M -$304K -$190K
Free Cash Flow -$383.7M -$234.0M -$173.3M -$116.9M -$89.02M -$62.21M -$46.87M -$20.52M -$9.78M -$5.66M
Purchases of Investments -$1.00B -$1.15B -$527.9M -$329.8M -$125.4M -$135.6M -$108.1M -$118.4M -- --
Investing Cash Flow $173.9M -$574.8M -$200.4M -$174.0M -$56.48M $217K $41.67M -$119.5M -$304K -$190K
Common Stock Issued $0 $985.0M $369.6M $117.2M $249.5M $114.3M -- $106.5M -- --
Financing Cash Flow $40.61M $1.01B $391.2M $122.0M $252.7M $114.6M $67K $170.2M $11.82M -$53K
Net Change in Cash -$163.4M $209.6M $22.22M -$167.2M $107.6M $52.76M -$4.65M $31.28M $2.04M -$5.71M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$120.9M -$127.8M -$122.8M -$130.1M -$115.6M -$96.77M -$80.59M -$76.83M
Depreciation & Amortization $1.07M $1.16M $994K $1.01M $959K $925K $788K $770K
Stock-Based Compensation $24.88M $29.68M $21.72M $22.70M $26.12M $20.48M $18.84M $18.15M
Change in Receivables -$6.27M -$5.09M -- -- $0 $0 -- --
Change in Inventory -$358K -$909K -- -- $0 $0 -- --
Operating Cash Flow -$94.19M -$124.7M -$92.90M -$110.7M -$85.85M -$88.45M -$66.87M -$62.82M
Capital Expenditure -$521K -$820K -$458K -$863K -$3.20M -$1.24M -$1.03M -$528K
Free Cash Flow -$94.71M -$125.5M -$93.36M -$111.6M -$89.05M -$89.69M -$67.90M -$63.35M
Purchases of Investments -$155.2M -$554.4M -$213.6M -$216.7M -$182.9M -$391.2M -$725.0M -$130.0M
Investing Cash Flow $26.29M -$252.4M $57.11M $164.8M $37.95M -$85.96M -$542.1M $20.60M
Common Stock Issued $0 $380.5M $0 $0 $0 $0 $543.5M $48.14M
Financing Cash Flow $8.93M $389.9M $26.04M $3.08M $7.05M $4.44M $556.2M $57.33M
Net Change in Cash -$58.98M $12.81M -- $57.17M -$40.84M -$170.0M -$52.72M $15.11M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 86.0% 100.0% 100.0% -- -- -- -- -- -- --
Operating Margin -6714.8% -32613.5% -5547.2% -3544.1% -9990.9% -105567.6% -4512.3% -1182.5% -446.3% -1026.1%
Net Profit Margin -6046.2% -28720.7% -5345.9% -3460.4% -9985.3% -103960.6% -4226.5% -1116.8% -447.8% -1021.9%
Return on Equity (ROE) -46.9% -22.5% -39.8% -51.8% -32.4% -43.7% -43.0% -16.9% -- --
Return on Assets (ROA) -41.3% -20.8% -33.8% -46.5% -30.7% -40.2% -38.7% -15.8% -58.7% --
Current Ratio 12.32x 23.04x 13.07x 12.45x 21.55x 16.92x 14.79x 21.03x 16.91x --
Quick Ratio 12.30x 23.04x 12.71x 12.06x 20.86x 16.29x 14.20x 20.68x 15.82x --
Debt to Equity 0.05x 0.04x 0.10x 0.01x 0.01x 0.03x 0.05x -- -- --
Revenue Growth (YoY) +640.7% -74.1% -15.3% +339.4% +1418.3% -94.0% -50.9% +18.7% +247.2% --
Gross Profit Growth (YoY) +537.2% -74.1% -- -- -- -- -- -- -- --
5Y Revenue / Share Growth +3408.9% -73.9% -65.4% -93.9% -95.2% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Operating Margin -1302.5% -3020.3% -6714.8% -31130.2% -30392.2% -49569.7% -32613.5% -29525.2%
Net Profit Margin -1189.9% -2747.2% -6046.2% -27563.3% -26568.5% -43191.1% -28720.7% -26747.8%
Return on Equity (ROE) -42.1% -38.8% -46.9% -39.5% -31.6% -26.2% -22.5% -33.4%
Return on Assets (ROA) -37.9% -35.4% -41.3% -35.4% -28.7% -24.1% -20.8% -29.6%
Current Ratio 15.57x 18.60x 12.32x 15.12x 17.80x 22.53x 23.04x 16.38x
Quick Ratio 15.53x 18.56x 12.30x 14.83x 17.54x 22.68x 23.04x 16.11x
Debt to Equity 0.04x 0.04x 0.05x 0.05x 0.04x 0.04x 0.04x 0.06x
Revenue Growth (YoY) +2336.3% +2873.4% -- -- +158.4% -43.6% -- -100.0%
Gross Profit Growth (YoY) +2321.3% +2818.0% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001658247) · from December 31, 2016 Data through June 30, 2026 · synced Nov 20, 2026, 05:10 UTC · Open in terminal